Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-058967
Filing Date
2017-11-02
Accepted
2017-11-02 18:13:52
Documents
2
Period of Report
2017-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4102
2 POA DOCUMENT poa.txt EX-24.4_750250 3475
  Complete submission text file 0001209191-17-058967.txt   8880
Mailing Address 7 CLARKE DRIVE CRANBURY NJ 08512
Business Address 7 CLARKE DRIVE CRANBURY NJ 08512 6096193990
Oncobiologics, Inc. (Issuer) CIK: 0001649989 (see all company filings)

EIN.: 383982704 | State of Incorp.: DE | Fiscal Year End: 0930
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address TONISHOFSTRASSE 15 WALCHWIL V8 6318
Business Address
Albrecht Claudio (Reporting) CIK: 0001718003 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37759 | Film No.: 171174004